-
EP1871368
European procedure
Extract from the Register of European Patents
EP About this file: EP1871368
| EP1871368 - DIHYDROPYRIDINE COMPOUNDS FOR NEURODEGENERATIVE DISEASES AND DEMENTIA [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 13.04.2012 Database last updated on 01.04.2026 | Most recent event Tooltip | 06.02.2015 | Change - lapse in a contracting state | published on 11.03.2015 [2015/11] | Applicant(s) | For all designated states Eisai R&D Management Co., Ltd. 6-10, Koishikawa 4-chome Bunkyo-ku Tokyo 112-8088 / JP | [N/P] |
| Former [2011/14] | For all designated states Eisai R&D Management Co., Ltd. 6-10, Koishikawa 4-chome Bunkyo-ku Tokyo 112-8088 / JP | ||
| Former [2008/13] | For all designated states Eisai R&D Management Co., Ltd. 6-10, Koishikawa 4-chome Bunkyo, Tokyo / JP | ||
| Former [2008/01] | For all designated states Eisai Co., Ltd. 6-10, Koishikawa 4-chome, Bunkyo-ku Tokyo 112-8088 / JP | Inventor(s) | 01 /
GRAY, Julian, A. Blumenacker 33 D-79594 Inzlingen / DE | 02 /
YOSHIHARU, Yamanishi EISAI CO., LTD. 5-1-3 Tokodai Tsukuba-shi, Ibaraki, 300-2635 / JP | 03 /
NOBUYUKI, Mori EISAI CO., LTD. 5-1-3 Tokodai Tsukuba-shi, Ibaraki 300-2635 / JP | 04 /
FIELDS, Scott EISAI MEDICAL RESEARCH INC. 55 Challenger Road Ridgefield Park, New Jersey 07660 / US | [2008/01] | Representative(s) | Woods, Geoffrey Corlett J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | [N/P] |
| Former [2008/29] | Woods, Geoffrey Corlett J.A. KEMP & CO. 14 South Square Gray's Inn London WC1R 5JJ / GB | ||
| Former [2008/01] | Woods, Geoffrey Corlett J.A. Kemp & Co 14 South Square Gray's Inn GB-London WC1R 5JJ / GB | Application number, filing date | 06740387.3 | 04.04.2006 | [2008/01] | WO2006US12284 | Priority number, date | US20050667665P | 04.04.2005 Original published format: US 667665 P | US20050689519P | 13.06.2005 Original published format: US 689519 P | [2008/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2006107859 | Date: | 12.10.2006 | Language: | EN | [2006/41] | Type: | A2 Application without search report | No.: | EP1871368 | Date: | 02.01.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.10.2006 takes the place of the publication of the European patent application. | [2008/01] | Type: | B1 Patent specification | No.: | EP1871368 | Date: | 08.06.2011 | Language: | EN | [2011/23] | Search report(s) | International search report - published on: | US | 09.04.2009 | (Supplementary) European search report - dispatched on: | EP | 09.10.2009 | Classification | IPC: | A61K31/445, A61K31/4412, A61P25/28 | [2009/46] | CPC: |
A61K31/4412 (EP,US);
A61K31/445 (EP,KR,US);
A61K31/444 (EP,KR,US);
A61P25/06 (EP);
A61P25/14 (EP);
A61P25/16 (EP);
| C-Set: |
A61K31/4412, A61K2300/00 (EP,US);
A61K31/444, A61K2300/00 (US,EP);
A61K31/445, A61K2300/00 (US,EP)
|
| Former IPC [2009/22] | A61K31/44, A01N43/40 | ||
| Former IPC [2008/01] | A61K31/445, A61K31/444 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/01] | Extension states | AL | 02.11.2007 | BA | 02.11.2007 | HR | 02.11.2007 | MK | 02.11.2007 | YU | 02.11.2007 | Title | German: | DIHYDROPYRIDIN-VERBINDUNGEN FÜR NEURODEGENERATIVE ERKRANKUNGEN UND DEMENZ | [2008/01] | English: | DIHYDROPYRIDINE COMPOUNDS FOR NEURODEGENERATIVE DISEASES AND DEMENTIA | [2008/01] | French: | COMPOSES DE DIHYDROPYRIDINE UTILISES POUR TRAITER DES MALADIES NEURODEGENERATIVES ET LA DEMENCE | [2008/01] | Entry into regional phase | 02.11.2007 | National basic fee paid | 02.11.2007 | Search fee paid | 02.11.2007 | Designation fee(s) paid | 02.11.2007 | Examination fee paid | Examination procedure | 02.11.2007 | Examination requested [2008/01] | 26.03.2008 | Amendment by applicant (claims and/or description) | 07.06.2010 | Despatch of a communication from the examining division (Time limit: M02) | 22.07.2010 | Reply to a communication from the examining division | 01.10.2010 | Communication of intention to grant the patent | 31.01.2011 | Fee for grant paid | 31.01.2011 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 07.06.2010 | Opposition(s) | 09.03.2012 | No opposition filed within time limit [2012/20] | Fees paid | Renewal fee | 28.03.2008 | Renewal fee patent year 03 | 16.04.2009 | Renewal fee patent year 04 | 25.03.2010 | Renewal fee patent year 05 | 12.04.2011 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | |||
| Former [2011/50] | CY | 08.06.2011 | Documents cited: | Search | [DY] US2004023973 (NAGATO SATOSHI et al.) [DY] 1-8 * [0018], [0108] * | [Y] SHIGETA M ET AL: "DONEPEZIL FOR ALZHEIMER'S DISEASE: PHARMACODYNAMIC, PHARMACOKINETIC, AND CLINICAL PROFILES", CNS DRUG REVIEWS, BRANFORD, CT, US, vol. 7, no. 4, 21 December 2001 (2001-12-21), pages 353 - 368, XP009028267, ISSN: 1080-563X [Y] 1-8 * page 364, paragraph entitled "Conclusions" * | by applicant | SHIGETA ET AL., CNS DRUG REVIEWS, vol. 7, no. 4, 21 December 2001 (2001-12-21), pages 353 - 368 | ERIXON-LINDROTHA ET AL., PSYCHIATRY RESEARCH: NEUROIMAGING, vol. 138, 2005, pages 1 - 12 | LUCIANA ET AL., CEREB. CORTEX., vol. 8, 1998, pages 218 - 226 | KIMBERG ET AL., NEUROPSYCHOLOGIA, vol. 41, 2003, pages 1020 - 1027 | GIACOBINI ET AL., NEUROPHARMACOLOGY, vol. 35, 1996, pages 205 - 211 | TAKAHATA ET AL., EUR. J. PHARMACOT., vol. 518, 2005, pages 140 - 144 | BUBSER ET AL., EUR. J. PHARMACOL., vol. 229, 1992, pages 75 - 82 | TARIOT ET AL., JAMA, vol. 291, 2004, pages 317 - 324 | REGO ET AL., NEUROCHEMICAL RESEARCH, vol. 28, 2003, pages 1563 - 1574 | OHNO ET AL., JPET, vol. 306, 2003, pages 66 - 72 | MATSUOKA ET AL., NEUROREPORT, vol. 6, 1995, pages 2205 - 2208 | KRISTENSEN, BRAIN RES., vol. 917, 2001, pages 21 - 44 | AKASOFU ET AL., EUR. J. PHARMACOL., vol. 530, 2006, pages 215 - 222 | HASHIMOTO ET AL., AM J. PSYCHIATRY, vol. 162, 2005, pages 676 - 682 | PRINGLE ET AL., BRAIN RESEARCH, vol. 755, 1997, pages 36 - 46 | PRINGLE ET AL., STROKE, vol. 27, 1996, pages 2124 - 2130 | MORRISON ET AL., BR. J. PHARMACOL., vol. 137, 2002, pages 1255 - 1268 | WILDE ET AL., J NEUROCHEM., vol. 69, no. 2, 1997, pages 883 - 886 | MORRISON ET AL., BR. J PHARMACOL., vol. 137, 2002, pages 1255 - 1268 | AKASOFU ET AL., EUR. J PHARMACOL., vol. 472, no. 1-2, 2003, pages 57 - 63 | TAKADA ET AL., PHARMACOL. EXP. THER., vol. 306, no. 2, 2003, pages 772 - 777 |